The MarketWatch News Department was not involved in the creation of this content. -- Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with ...

Artbio, a start-up with a focus on developing radiopharmaceuticals to treat cancer, pulls its name right from its medicines—alpha radioligand therapies (ART). The nascent firm, with roots in Norway, ...

Alpha DaRT, a unique localized alpha radiation therapy, has shown potential best-in-class efficacy and safety across multiple solid tumors. Currently enrolling patients in cSCC, HNSCC, pancreatic, and ...

Efficacy, safety, and quality of life outcomes of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A GRADE-assessed systematic review, meta-analysis, and trial sequential analysis of ...

Targeted radiopharmaceutical therapy with alpha-particle emitters (αRPT) is advantageous in cancer treatment because the short range and high local energy deposition of alpha particles enable precise ...

Scientists have developed tiny nanocrystal particles made up of isotopes of the elements lanthanum, vanadium, and oxygen for use in treating cancer. (Nanowerk News) Scientists have developed tiny ...

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current ...

– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer – This clinical trial is designed based on the results of an ...